183 related articles for article (PubMed ID: 17581318)
1. Utility of the PFA-100 as a screening test of platelet function: an audit of haemostasis laboratories in Australia and New Zealand.
Favaloro EJ; Bonar R; Duncan E; Rodgers S; Marsden K;
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):441-8. PubMed ID: 17581318
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of the PFA-100.
Favaloro EJ
Semin Thromb Hemost; 2008 Nov; 34(8):709-33. PubMed ID: 19214910
[TBL] [Abstract][Full Text] [Related]
3. The utility of the PFA-100 in the identification of von Willebrand disease: a concise review.
Favaloro EJ
Semin Thromb Hemost; 2006 Jul; 32(5):537-45. PubMed ID: 16862528
[TBL] [Abstract][Full Text] [Related]
4. The platelet function analyzer (PFA-100): an update on its clinical use.
Franchini M
Clin Lab; 2005; 51(7-8):367-72. PubMed ID: 16122146
[TBL] [Abstract][Full Text] [Related]
5. External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update.
Favaloro EJ; Bonar R
Semin Thromb Hemost; 2014 Mar; 40(2):239-53. PubMed ID: 24497116
[TBL] [Abstract][Full Text] [Related]
6. PFA-100 system: a new method for assessment of platelet dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
[TBL] [Abstract][Full Text] [Related]
7. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.
Favaloro EJ
Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567
[TBL] [Abstract][Full Text] [Related]
8. Methodology and outcomes of platelet aggregation testing in Australia, New Zealand and the Asia-Pacific region: results of a survey from the Royal College of Pathologists of Australasia Haematology Quality Assurance Program.
Duncan EM; Bonar R; Rodgers SE; Favaloro EJ; Marsden K;
Int J Lab Hematol; 2009 Aug; 31(4):398-406. PubMed ID: 18371058
[TBL] [Abstract][Full Text] [Related]
9. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time.
Philipp CS; Miller CH; Faiz A; Dilley A; Michaels LA; Ayers C; Bachmann G; Dowling N; Saidi P
Haemophilia; 2005 Sep; 11(5):497-503. PubMed ID: 16128894
[TBL] [Abstract][Full Text] [Related]
10. The platelet-function analyzer (PFA-100) for evaluating primary hemostasis.
Franchini M
Hematology; 2005 Jun; 10(3):177-81. PubMed ID: 16019466
[TBL] [Abstract][Full Text] [Related]
11. Platelet function testing: auditing local practice and broader implications.
Favaloro EJ; Mohammed S
Clin Lab Sci; 2010; 23(1):21-31. PubMed ID: 20218091
[TBL] [Abstract][Full Text] [Related]
12. [New in vitro analysis tested: bleeding time is still the best method for evaluation of primary hemostasis].
Ridefelt P; Egberg N; Hillarp A; Lethagen S; Tengborn L
Lakartidningen; 2001 Sep; 98(37):3922-4. PubMed ID: 11586831
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
Favaloro EJ
Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
[TBL] [Abstract][Full Text] [Related]
14. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults.
Harrison P
Br J Haematol; 2005 Jul; 130(1):3-10. PubMed ID: 15982339
[TBL] [Abstract][Full Text] [Related]
15. Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting.
Rand ML; Carcao MD; Blanchette VS
Semin Thromb Hemost; 1998; 24(6):523-9. PubMed ID: 10066147
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of the PFA-100.
Favaloro EJ
Curr Opin Hematol; 2002 Sep; 9(5):407-15. PubMed ID: 12172459
[TBL] [Abstract][Full Text] [Related]
17. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
[TBL] [Abstract][Full Text] [Related]
18. Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations.
Favaloro EJ
Haemophilia; 2001 Mar; 7(2):170-9. PubMed ID: 11260277
[TBL] [Abstract][Full Text] [Related]
19. Emerging technologies and quality assurance in hemostasis: a review of findings from the Royal College of Pathologists of Australasia Quality Assurance Program.
Favaloro EJ; Bonar R
Semin Thromb Hemost; 2007 Apr; 33(3):235-42. PubMed ID: 17427057
[TBL] [Abstract][Full Text] [Related]
20. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
Giannini S; Mezzasoma AM; Leone M; Gresele P
Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
